Bravatek Solutions, Inc. BVTK
BVTK was among our mentions in Wednesday's premarket report after it was unearthed in our chatroom* the previous morning before making a 500% move. Those who missed that run got another chance right away as the stock ran from .0009-.0035 that afternoon, and topped out at .0041 to close out the short week on Friday. That added another two-day swing of 355% to the activity we had observed in BVTK, which was followed by a pullback to .0015.
Once again, to kick off the new trading week yesterday, BVTK began to run, returning to a high of .0034 on the day, representing yet another two-day upswing out of this volatile runner amounting to 127% The stock ended the session having traded roughly three-and-a-half times its monthly average volume. Things could get very interesting if it can manage to crack resistance at the previous swing high of .0041.
The company filed an 8-K this morning as well , pertaining to an agreement with i3 Integrative Creative Solutions, pursuant to which i3 Integrative will promote and solicit commitments in the United States federal government military and civilian markets regarding the Company’s cybersecurity email software and telecom services. (>>View Filing)
*We encourage all of our readers to join in on our daily in-session live chats. To participate, simply create/sign into your Skype account and send a contact request to ‘stocksumo’.
Bank of America Corp BAC – Options Ideas
Whenever we spot an opportunity to swoop in post-earnings with some options ideas, we jump on it right away, and that's what we have with BAC this morning.
We haven't highlighted this stock in quite awhile,but with a very solid beat on earnings and a small gap-up in the premarket, we're going to want to signal a couple of short term contracts for observation in the BAC Weekly $22.50 and $23 Calls.
In the event that a more sustained rebound is in the cards, considering the fact that BAC was already coming off of a relative bottom just yesterday, we'll have the BAC 05/12 $23.50 & $24 Calls on watch as well.
We want to put an observational tag on both Sorrento Therapeutics, Inc. SRNE and OncoMed Pharmaceuticals, Inc. OMED. Both of these stocks have taken serious beatings of late, and consequently, are in extreme oversold territory. Chances for recovery plays here seem quite high, so we're going to watch for these to establish higher lows in sessions ahead.
Extended Watchlist: JAMN, MYDX, CAB, SSYS, BIOC, NFLX